Q4 2024. Management View. CEO Marc Biron highlighted that 2024 was marked by an unusual market environment, with sales remaining b ...
Novo Nordisk (NVO) stock and Eli Lilly (LLY) stock higher as Novo (NVO) reports strong Q4 2024 earnings, driven by sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback